Some studies revealed that shorter GT repeats in the hmox-1 promoter region are associated with lower incidence and/or progression of CAD (Kaneda et al., 2002; Liang et al., 2013), whereas others argue against a relevant role of this polymorphism in cardiovascular diseases (Lublinghoff et al., 2009). Here, HMOX1 is linked to cardiovascular disorder.